Procyon Advisors, LLC Eli Lilly & CO Transaction History

Procyon Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Procyon Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Procyon Advisors, LLC holds 3,523 shares of LLY stock, worth $2.8 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

3,523

Previous 3,605 2.27%

Holding current value

$2.8 Million

Previous $3.26 Million 4.35%

% of portfolio

0.22%

Previous 0.24%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$772.14 - $960.02 $63,315 - $78,721	-82 Reduced 2.27%	3,523 $3.12 Million
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $8,698 - $10,908	12 Added 0.33%	3,605 $3.26 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $136,798 - $183,016	-231 Reduced 6.04%	3,593 $2.8 Million
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $269,947 - $318,232	514 Added 15.53%	3,824 $2.23 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $386,013 - $532,178	888 Added 36.66%	3,310 $1.78 Million
Q2 2023 Jul 17, 2023	BUY	$350.74 - $468.98 $35,074 - $46,898	100 Added 4.31%	2,422 $1.14 Million
Q1 2023 Apr 10, 2023	BUY	$310.63 - $364.82 $70,823 - $83,178	228 Added 10.89%	2,322 $797,000
Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $244,378 - $284,749	760 Added 56.97%	2,094 $0
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $91,315 - $104,063	-308 Reduced 18.76%	1,334 $431,000
Q2 2022 Jul 11, 2022	BUY	$278.73 - $327.27 $5,574 - $6,545	20 Added 1.23%	1,642 $532,000
Q1 2022 Apr 18, 2022	SELL	$234.69 - $291.66 $72,284 - $89,831	-308 Reduced 15.96%	1,622 $464,000
Q4 2021 Jan 18, 2022	SELL	$224.85 - $279.04 $21,585 - $26,787	-96 Reduced 4.74%	1,930 $533,000
Q3 2021 Oct 14, 2021	BUY	$221.6 - $272.71 $4,432 - $5,454	20 Added 1.0%	2,026 $468,000
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $13,541 - $17,515	75 Added 3.88%	2,006 $460,000
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $164 - $212	-1 Reduced 0.05%	1,931 $361,000
Q4 2020 Jan 19, 2021	SELL	$130.46 - $172.63 $35,876 - $47,473	-275 Reduced 12.46%	1,932 $326,000
Q3 2020 Oct 22, 2020	BUY	$146.22 - $169.13 $9,065 - $10,486	62 Added 2.89%	2,207 $327,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $29,739 - $35,791	-218 Reduced 9.23%	2,145 $352,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $14,047 - $17,387	118 Added 5.26%	2,363 $328,000
Q4 2019 Feb 21, 2020	BUY	$106.92 - $132.43 $240,035 - $297,305	2,245 New	2,245 $295,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Account

Procyon Advisors, LLC Eli Lilly & CO Transaction History